Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing ocular myasthenia

R D Rollinson, G M Fenichel

    Neurology
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Childhood ocular myasthenia can recur after long remissions, sometimes multiple times. Oral steroids effectively treat these recurrences, leading to sustained remission.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Lhermitte phenomenon: variant forms and their significance.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2008
    Same author

    A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy.

    Neurology·2001
    Same author

    Pediatric manifestations of Hashimoto's encephalopathy.

    Pediatric neurology·1999
    Same author

    Assessment: Neurologic risk of immunization [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

    Neurology·1999
    Same author

    Brachial neuritis following routine childhood immunization for diphtheria, tetanus, and pertussis (DTP): report of two cases and review of the literature.

    Pediatrics·1997
    Same author

    Chronic post-traumatic headache often a myth?

    Neurology·1996
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Area of Science:

    • Neurology
    • Ophthalmology
    • Immunology

    Background:

    • Ocular myasthenia gravis (OMG) is an autoimmune disorder affecting neuromuscular junctions in the eye muscles.
    • Childhood-onset OMG presents unique challenges regarding disease course and long-term prognosis.

    Observation:

    • Three pediatric patients with OMG experienced prolonged spontaneous remissions lasting 4 to 14 years.
    • One patient demonstrated a pattern of relapse and spontaneous remission before a final relapse.

    Findings:

    • Recurrences of OMG occurred after extended periods of remission in all observed cases.
    • All patients achieved remission with the initiation of oral steroid therapy.

    Implications:

    • The potential for late recurrences in childhood OMG necessitates long-term patient monitoring.
  • Oral corticosteroids represent an effective therapeutic strategy for managing recurrent ocular myasthenia gravis.